The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2012
DOI: 10.1001/archdermatol.2012.1545
|View full text |Cite
|
Sign up to set email alerts
|

Intertriginous Mycosis Fungoides

Abstract: Background: Follicular helper T cells are a subset of helper T cells that facilitate B-cell recruitment and maturation. Rare cases of cutaneous T-cell lymphoma manifesting as de novo tumor lesions in intertriginous skin contain an infiltrate rich in B cells. These cases may represent malignant counterparts of skin-homing follicular helper T cells. Observations: Two men and 1 woman (age range, 35-58 years) were seen with predominantly intertriginous tumorstage cutaneous T-cell lymphoma lesions characterized by … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 16 publications
(1 citation statement)
references
References 13 publications
0
1
0
Order By: Relevance
“…[23][24][25] It has been postulated that the expression of CD10 differentiates systemic from cutaneous lymphomas, but evidence indicating some cases of CD10 + MF and CD4 + SMLPD denies this correlation. 24 Some recent papers have described a subset of cases of "intertriginous MF" 26,27 with an aggressive course and a TFH phenotype, particularly an intertriginous variant of MF expressing TFH markers (CD10 + , PD1 + ) that progressed to SS within 2 years. 26 However, although these cases share the clinical localisation and some of the histopathological and phenotypical features of our case, it would be too speculative to correlate this phenotypical presentation with prognosis.…”
Section: Discussionmentioning
confidence: 99%
“…[23][24][25] It has been postulated that the expression of CD10 differentiates systemic from cutaneous lymphomas, but evidence indicating some cases of CD10 + MF and CD4 + SMLPD denies this correlation. 24 Some recent papers have described a subset of cases of "intertriginous MF" 26,27 with an aggressive course and a TFH phenotype, particularly an intertriginous variant of MF expressing TFH markers (CD10 + , PD1 + ) that progressed to SS within 2 years. 26 However, although these cases share the clinical localisation and some of the histopathological and phenotypical features of our case, it would be too speculative to correlate this phenotypical presentation with prognosis.…”
Section: Discussionmentioning
confidence: 99%